| Date Filed | Type | Description |
| 08/25/2023 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Eterna Therapeutics Inc.|
Txns:
| Bought options to buy
@ $3300000, valued at
$0
Bought 2,307,692 warrants
@ $0.125, valued at
$288.5k
|
|
| 08/10/2023 |
4
| BINDER BRANT (Former director) has filed a Form 4 on Eterna Therapeutics Inc. |
| 08/10/2023 |
4
| WAGNER RICHARD W (Former director) has filed a Form 4 on Eterna Therapeutics Inc. |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| WAGNER RICHARD W (Director) has filed a Form 4 on Eterna Therapeutics Inc.|
Txns:
| Bought options to buy
@ $2.86, valued at
$0
Bought 83,916 warrants
@ $2.61, valued at
$219k
|
|
| 07/18/2023 |
4
| Freebird Partners LP (10% Owner) has filed a Form 4 on Eterna Therapeutics Inc.|
Txns:
| Bought 262,237 options to buy
@ $2.86, valued at
$750k
Bought 524,474 warrants
@ $2.61, valued at
$1.4M
|
|
| 07/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/04/2023 |
3
| Freebird Partners LP (10% Owner) has filed a Form 3 on Eterna Therapeutics Inc. |
| 03/06/2023 |
3
| DENNY GEORGE P III (10% Owner) has filed a Form 3 on Eterna Therapeutics Inc. |
| 01/13/2023 |
4
| Angel Matthew (President and CEO) has filed a Form 4 on Eterna Therapeutics Inc.|
Txns:
| Granted 132,003 options to buy
@ $4.84, valued at
$638.9k
|
|
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2022 |
4
| Sidhu Roger (Chief Medical Officer) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Exercised 20,163 restricted stock units
@ $0 |
|
| 08/03/2022 |
4
| Angel Matthew (Interim President and CEO) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 2,487,003 options to buy
@ $0.49, valued at
$1.2M
|
|
| 08/03/2022 |
4
| Cherington Charles (Director) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 215,100 options to buy
@ $0.49, valued at
$105.4k
Granted 165,800 options to buy
@ $0.49, valued at
$81.2k
|
|
| 08/03/2022 |
4
| Fiore Gregory (Director) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 95,100 options to buy
@ $0.49, valued at
$46.6k
Granted 165,800 options to buy
@ $0.49, valued at
$81.2k
|
|
| 08/03/2022 |
4
| Wexler William A. (Director) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 152,100 options to buy
@ $0.49, valued at
$74.5k
Granted 165,800 options to buy
@ $0.49, valued at
$81.2k
|
|
| 08/03/2022 |
4
| Singer Nicholas Jason (Director) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 146,100 options to buy
@ $0.49, valued at
$71.6k
Granted 165,800 options to buy
@ $0.49, valued at
$81.2k
|
|
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Gurrola Sandra M (Vice President of Finance) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,586 shares
@ $0.4765, valued at
$1.7k
Exercised 8,750 restricted stock units
@ $0 |
|
| 06/07/2022 |
3
| Singer Nicholas Jason (Director) has filed a Form 3 on Brooklyn ImmunoTherapeutics, Inc. |
| 06/07/2022 |
3
| Wexler William A. (Director) has filed a Form 3 on Brooklyn ImmunoTherapeutics, Inc. |
| 06/07/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/06/2022 |
4
| Jackson Andrew C. (CFO) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 664,800 options to buy
@ $0.6086, valued at
$404.6k
|
|
| 06/01/2022 |
3
| Jackson Andrew C. (CFO) has filed a Form 3 on Brooklyn ImmunoTherapeutics, Inc. |
| 06/01/2022 |
3
| Angel Matthew (Interim President and CEO) has filed a Form 3 on Brooklyn ImmunoTherapeutics, Inc. |
| 03/17/2022 |
4/A
| DAmour Kevin (Chief Scientific Officer) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 138,400 options to buy
@ $1.93, valued at
$267.1k
|
|
| 03/17/2022 |
4/A
| Gurrola Sandra M (Vice President of Finance) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 114,500 options to buy
@ $1.93, valued at
$221k
|
|
| 03/17/2022 |
4/A
| Federoff Howard J. (CEO & President) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 413,700 options to buy
@ $1.93, valued at
$798.4k
|
|
| 03/17/2022 |
4/A
| Sial Jay (Chief Administration Officer) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 117,200 options to buy
@ $1.93, valued at
$226.2k
|
|
| 03/17/2022 |
4/A
| Sidhu Roger (Chief Medical Officer) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 142,100 options to buy
@ $1.93, valued at
$274.3k
|
|
| 03/15/2022 |
4
| DAmour Kevin (Chief Scientific Officer) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 138,400 options to buy
@ $1.93, valued at
$267.1k
|
|
|